Pharmacovigilance Services

March 8, 2021

End-to-end pharmacovigilance support for a UK-based pharmaceutical company

APCER’s Pharmacovigilance (PV) team supported a client’s expansion into new markets by setting up a
March 8, 2021

Setting up Agile PV operations for a US based Pharma company

APCER’s Pharmacovigilance (PV) team helped a biotech pharmaceutical company with set up, training and database
March 8, 2021

Strengthening QPPV oversight through expert PSMF management for a global pharmaceutical company

APCER helped a leading generics company to streamline its PV related processes within 30 days.
March 8, 2021

Established a unifed, global PV system for a pharma company after multiple M&A

We helped a large pharmaceutical company successfully transition its pharmacovigilance (PV) processes and helped establish
March 8, 2021

Enabling global expansion by establishing an integrated PV system

APCER helped a global pharmaceutical company in establishing a collaborative global pharmacovigilance (PV) governance model;
March 8, 2021

Active remediation measures help mitigate major safety findings

March 8, 2021

Innovative Biotechnology Company Relies on APCER Life Sciences to Manage Complex Safety Reporting in Oncology Trials

APCER Life Sciences supported an innovative biotechnology company in managing complex pharmacovigilance and regulatory requirements
January 12, 2021

Importance of Engaging a Safety Partner Early in the Drug Life Cycle

Ms. Jeanne Schow, Vice President & US Head of Business Development talks the key benefits
January 10, 2021

Risk minimisation measures: Tracking and effectiveness assessment

January 6, 2021

RMP Team Collaboration Across Functions

January 6, 2021

aRMM Implementation Strategy

January 6, 2021

Identification of risks and determination of aRRM requirement

December 24, 2020

Need for successful launch of Mass Vaccination: Is the world ready?

October 1, 2020

Vaccine Strategies for COVID-19